Alume Biosciences Inc research brief

CIK 1782348 Copy CIK

Generated Nov. 6, 2026, 9:56 a.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.

Current stored business address: LA JOLLA CA. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.

• May 8, 2026 · D/A · 0001782348-26-000006 · Source evidence

  Reported offering amount: 8000000 USD. Reported amount sold: 2160000 USD.

• April 6, 2026 · D · 0001782348-26-000005 · Source evidence

  Reported offering amount: 8000000 USD. Reported amount sold: 110000 USD.

• Feb. 19, 2026 · D/A · 0001782348-26-000002 · Source evidence

  Reported offering amount: 23499998 USD. Reported amount sold: 6853305 USD.

• Jan. 30, 2026 · D/A · 0001782348-26-000001 · Source evidence

  Reported offering amount: 23499998 USD. Reported amount sold: 5967305 USD.

• Dec. 31, 2025 · D/A · 0001782348-25-000005 · Source evidence

  Reported offering amount: 23499998 USD. Reported amount sold: 5316105 USD.

• Nov. 12, 2025 · D/A · 0001782348-25-000004 · Source evidence

  Reported offering amount: 23499998 USD. Reported amount sold: 3611116 USD.

• Oct. 31, 2025 · D · 0001782348-25-000003 · Source evidence

  Reported offering amount: 23499998 USD. Reported amount sold: 3055500 USD.

Reviewed offering links

• No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.

Citation: Form D Explorer, “Alume Biosciences Inc research brief,” CIK 1782348, retrieved Nov. 6, 2026, 9:56 a.m.. Cite the specific accessions used. No amounts have been summed.